MEDIMMUNE, LLC
GAITHERSBURG, MD

You are about to access MedImmune historic archive material. Any reference in these archives to MedImmune products or their uses may not reflect current medical knowledge and should not be used as a source of information on the present product label, efficacy data or safety data. Please refer to your approved national product label (SmPC) for current product information. I have read this warning and will not be using any of the contained product information for clinical purposes. MedImmune founded Molecular Vaccines, Inc., founded by Wayne T. Hockmeyer, commences operations. In 1990, the company changed it's name to MedImmune. MedImmune receives U.S. Food and Drug Administration clearance to market RespiGam for the prevention of serious lower respiratory tract disease caused by respiratory synctial virus (RSV) in pediatric patients at high risk of RSV disease, and sales of the drug commence. MedImmune completes acquisition of U.S. Bioscience. This acquisition provides MedImmune with three marketed oncology and infectious disease products, as well as development capabilities and an oncology sales and marketing infrastructure. CAT acquires Aptein Incorporated. MedImmune and AstraZeneca AstraZeneca completes acquisition of MedImmune. MedImmune and Cambridge Antibody Technology (CAT) announce that CAT is changing its name to MedImmune to reflect AstraZeneca's vision for its worldwide biologics business. The new business unit unites the resources and expertise from CAT, the pre-existing MedImmune, and other biologics activities within the AstraZeneca Group, under the MedImmune name. MedImmune acquires AlphaCore Pharma, Amplimmune & Spirogen. You are about to access MedImmune historic archive material. Any reference in these archives to MedImmune products or their uses may not reflect current medical knowledge and should not be used as a source of information on the present product label, efficacy data or safety data. Please refer to your approved national product label (SmPC) for current product information. I have read this warning and will not be using any of the contained product information for clinical purposes. A proud Cambridge heritage: MedImmune in the UK With over 550 employees, MedImmune’s team at Granta Park is focused on the research and early development of our biologics portfolio. MedImmune has built on the local legacy of Cambridge Antibody Technology (CAT) – acquired by AstraZeneca and integrated with MedImmune in 2007 – where three marketed products (Humira, Benlysta and raxibacumab) were invented. MedImmune Cambridge has strong collaborative links with numerous academics, researchers, foundations and neighbouring companies in the largest biotech cluster in Europe and has an active outreach programme within the local community. MedImmune AstraZeneca, together with its global biologics research and development arm MedImmune, today revealed plans to bring together five of its Bay Area sites into one location in South San Francisco. The new site will be located in the Cove at Oyster Point with cutting-edge lab space and offices. More than 350 employees in existing AstraZeneca, Acerta Pharma, MedImmune, and Pearl R&D facilities will move to the new location beginning in Q4 2017. You are about to access MedImmune historic archive material. Any reference in these archives to MedImmune products or their uses may not reflect current medical knowledge and should not be used as a source of information on the present product label, efficacy data or safety data. Please refer to your approved national product label (SmPC) for current product information. I have read this warning and will not be using any of the contained product information for clinical purposes. Every summer, I spend one week at a camp for kids with cancer. I’ve been doing this for 15 years. Having MedImmune subsidize my participation at this terrific camp as part of its corporate responsibility volunteer initiative has been remarkably meaningful. For two years I helped to run a sponsored walk in Cambridge, UK to help raise money for Oxfam’s emergency fund. I compiled route maps and instructions, coordinated route signage and on the day I coordinated the whole event. It was fantastic to be part of the event and know that we were raising money for a worthy cause. I have been volunteering on weekends as a medic with Red Cross First Aid Service Team(FAST) for 3.5 years now. We provide basic life support to patients and escalate to more advanced medical support when there is a need. The safety of the patients who take our medicines is of fundamental importance to us. We set high standards of ethical practice across all aspects of our research activity worldwide, from clinical trials to our research with animals. We also work to ensure that we are aware of any risks to patient safety such as side effects or cases of product counterfeiting. Ethical business practices We are committed to delivering consistently high ethical standards of sales and marketing practices and to integrating ethical standards into our At MedImmune, relentless pursuit is matched with exceptional capabilities to break new ground in science. We’re constantly pushing the boundaries of science to deliver life-changing medicines to patients. We’re industry-leading in immunology, protein engineering and translational science and we thrive on collaboration. We offer our employees a diverse and modern workspace and we value work/life balance. Learn more about Life at MedImmune. At MedImmune, we believe in rewarding talent and performance. We do so by providing a competitive total compensation package to our employees including competitive salaries, opportunities to participate in our annual bonus and stock (LTI) programs, retirement savings and a long list of benefits. In addition, providing opportunity for development and advancement are part of our culture. We pride ourselves on being a great place to work. A confirmation e-mail thanking you for your application will be sent to you after you have submitted your résumé. Your application will be shared with the appropriate recruiter and should you be selected, you will be contacted regarding next steps. If you are invited for a telephone pre-screen interview, we will contact you directly via e-mail and you will be able to schedule the pre-screen, via an internet link, for a time that is convenient for you. Following your telephone pre-screen, if your background and skill sets match the position requirements, the recruiter will forward your information to the appropriate hiring manager for review. The hiring manager will review all appropriate applications for the job and will select the candidates who will be invited for an interview. If you are invited for an interview, we will contact you by telephone or e-mail to check your availability. The hiring manager may choose to follow up with you by conducting an additional phone interview, or may wish to bring you into the MedImmune facility for an in-person interview.Following the interviews, the hiring team evaluates all candidates against the job requirements, and the hiring manager selects the best qualified candidate. If you are selected, a recruitment representative will contact you to make a verbal offer. This will be followed by a written offer letter, in which we'll explain the next steps of our on-boarding process, including a pre-employment screen. Following your successful pre-employment screen, Human Resources will coordinate with the hiring department to ensure a smooth on-boarding and orientation process for you. If you are not selected to continue in the hiring process, you will be notified via e-mail. We encourage you to continue to search our career site and apply to other positions that fit your background and experience.